Literature DB >> 25424921

Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

Mevyn Nizard1, Mariana O Diniz, Helene Roussel, Thi Tran, Luis Cs Ferreira, Cecile Badoual, Eric Tartour.   

Abstract

The mucosal immune system displays several adaptations reflecting the exposure to the external environment. The efficient induction of mucosal immune responses also requires specific approaches, such as the use of appropriate administration routes and specific adjuvants and/or delivery systems. In contrast to vaccines delivered via parenteral routes, experimental, and clinical evidences demonstrated that mucosal vaccines can efficiently induce local immune responses to pathogens or tumors located at mucosal sites as well as systemic response. At least in part, such features can be explained by the compartmentalization of mucosal B and T cell populations that play important roles in the modulation of local immune responses. In the present review, we discuss molecular and cellular features of the mucosal immune system as well as novel immunization approaches that may lead to the development of innovative and efficient vaccines targeting pathogens and tumors at different mucosal sites.

Entities:  

Keywords:  cancer vaccines; homing molecules; immunization routes; mucosal adjuvants; mucosal imprinting; mucosal vaccines; resident memory T cells

Mesh:

Substances:

Year:  2014        PMID: 25424921      PMCID: PMC4896761          DOI: 10.4161/hv.29269

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  179 in total

1.  DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27.

Authors:  Hekla Sigmundsdottir; Junliang Pan; Gudrun F Debes; Carsten Alt; Aida Habtezion; Dulce Soler; Eugene C Butcher
Journal:  Nat Immunol       Date:  2007-01-28       Impact factor: 25.606

Review 2.  New horizon of mucosal immunity and vaccines.

Authors:  Ichiro Takahashi; Tomonori Nochi; Yoshikazu Yuki; Hiroshi Kiyono
Journal:  Curr Opin Immunol       Date:  2009-06-01       Impact factor: 7.486

3.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

4.  The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.

Authors:  N Haicheur; E Bismuth; S Bosset; O Adotevi; G Warnier; V Lacabanne; A Regnault; C Desaymard; S Amigorena; P Ricciardi-Castagnoli; B Goud; W H Fridman; L Johannes; E Tartour
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

Review 5.  Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut.

Authors:  N J Mantis; N Rol; B Corthésy
Journal:  Mucosal Immunol       Date:  2011-10-05       Impact factor: 7.313

6.  Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.

Authors:  Loane Decrausaz; Sonia Domingos-Pereira; Mélanie Duc; Martine Bobst; Pedro Romero; John T Schiller; Patrice Jichlinski; Denise Nardelli-Haefliger
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

7.  Two different homing pathways involving integrin β7 and E-selectin significantly influence trafficking of CD4 cells to the genital tract following Chlamydia muridarum infection.

Authors:  Kathleen A Kelly; Ann M Chan; Anthony Butch; Toni Darville
Journal:  Am J Reprod Immunol       Date:  2009-04-22       Impact factor: 3.886

8.  Boosting systemic and secreted antibody responses in mice orally immunized with recombinant Bacillus subtilis strains following parenteral priming with a DNA vaccine encoding the enterotoxigenic Escherichia coli (ETEC) CFA/I fimbriae B subunit.

Authors:  Wilson B Luiz; Rafael C M Cavalcante; Juliano D Paccez; Renata D Souza; Maria E Sbrogio-Almeida; Rita C C Ferreira; Luís C S Ferreira
Journal:  Vaccine       Date:  2008-06-02       Impact factor: 3.641

9.  Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge.

Authors:  M Mohamadzadeh; T Duong; S J Sandwick; T Hoover; T R Klaenhammer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

10.  Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues.

Authors:  Daniel J Campbell; Eugene C Butcher
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  14 in total

Review 1.  Therapeutic cancer vaccine: building the future from lessons of the past.

Authors:  T Tran; C Blanc; C Granier; A Saldmann; C Tanchot; Eric Tartour
Journal:  Semin Immunopathol       Date:  2018-07-05       Impact factor: 9.623

2.  Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles.

Authors:  Rodney Macedo; Juliette Rochefort; Maude Guillot-Delost; Kae Tanaka; Aline Le Moignic; Clara Noizat; Claude Baillou; Véronique Mateo; Antoine F Carpentier; Eric Tartour; Chloé Bertolus; Bertrand Bellier; Géraldine Lescaille; François M Lemoine
Journal:  Oncoimmunology       Date:  2016-07-06       Impact factor: 8.110

3.  Oral Vaccination with Attenuated Salmonella typhimurium-Delivered TsPmy DNA Vaccine Elicits Protective Immunity against Trichinella spiralis in BALB/c Mice.

Authors:  Lei Wang; Xiaohuan Wang; Kuo Bi; Ximeng Sun; Jing Yang; Yuan Gu; Jingjing Huang; Bin Zhan; Xinping Zhu
Journal:  PLoS Negl Trop Dis       Date:  2016-09-02

4.  Recombinant Invasive Lactococcus lactis Carrying a DNA Vaccine Coding the Ag85A Antigen Increases INF-γ, IL-6, and TNF-α Cytokines after Intranasal Immunization.

Authors:  Pamela Mancha-Agresti; Camila Prosperi de Castro; Janete S C Dos Santos; Maíra A Araujo; Vanessa B Pereira; Jean G LeBlanc; Sophie Y Leclercq; Vasco Azevedo
Journal:  Front Microbiol       Date:  2017-07-11       Impact factor: 5.640

5.  Induction of resident memory T cells enhances the efficacy of cancer vaccine.

Authors:  Mevyn Nizard; Hélène Roussel; Mariana O Diniz; Soumaya Karaki; Thi Tran; Thibault Voron; Estelle Dransart; Federico Sandoval; Marc Riquet; Bastien Rance; Elie Marcheteau; Elizabeth Fabre; Marion Mandavit; Magali Terme; Charlotte Blanc; Jean-Baptiste Escudie; Laure Gibault; Françoise Le Pimpec Barthes; Clemence Granier; Luis C S Ferreira; Cecile Badoual; Ludger Johannes; Eric Tartour
Journal:  Nat Commun       Date:  2017-05-24       Impact factor: 14.919

6.  Lactobacillus plantarum producing a Chlamydia trachomatis antigen induces a specific IgA response after mucosal booster immunization.

Authors:  Katarzyna Kuczkowska; Ine Myrbråten; Lise Øverland; Vincent G H Eijsink; Frank Follmann; Geir Mathiesen; Jes Dietrich
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240

7.  Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus.

Authors:  Kaitlyn M Morabito; Tracy J Ruckwardt; Erez Bar-Haim; Deepika Nair; Syed M Moin; Alec J Redwood; David A Price; Barney S Graham
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

8.  Editorial: Tissue Resident Memory T Cells.

Authors:  Fathia Mami-Chouaib; Eric Tartour
Journal:  Front Immunol       Date:  2019-05-27       Impact factor: 7.561

9.  Mucosal Vaccination Primes NK Cell-Dependent Development of CD8+ T Cells Against Pulmonary Brucella Infection.

Authors:  Ella Bhagyaraj; Hongbin Wang; Xinghong Yang; Carol Hoffman; Ali Akgul; Zakia I Goodwin; David W Pascual
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

10.  Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours.

Authors:  Lukasz Bialkowski; Alexia van Weijnen; Kevin Van der Jeught; Dries Renmans; Lidia Daszkiewicz; Carlo Heirman; Geert Stangé; Karine Breckpot; Joeri L Aerts; Kris Thielemans
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.